Literature DB >> 15196201

Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Sven Brode1, Paul A Macary.   

Abstract

As immunologists, our knowledge of the molecular mechanisms which underlie the presentation of antigens derived from extracellular or 'exogenous' sources to CD8 cytotoxic lymphocytes (CTL) has been limited. This process, termed 'cross-presentation', has been linked to the elicitation of protective CTL responses against tumours and may be extremely important in generating immune responses against clinically relevant pathogens that do not infect tissues of haemopoietic origin. It is now known that cross-presentation of exogenous antigens on major histocompatibility complex (MHC) class I occurs through several distinct cellular pathways. In this review we outline and discuss some recent advances in our understanding of these pathways.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15196201      PMCID： PMC1782510          DOI： 10.1111/j.1365-2567.2004.01920.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  73 in total

1.  Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1.

Authors:  Anne L Ackerman; Peter Cresswell
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

2.  Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.

Authors:  Gregory Lizée; Genc Basha; Jacqueline Tiong; Jean-Pierre Julien; Meimei Tian; Kaan E Biron; Wilfred A Jefferies
Journal:  Nat Immunol       Date:  2003-10-19       Impact factor: 25.606

3.  CpG-DNA aided cross-priming by cross-presenting B cells.

Authors:  Antje Heit; Katharina M Huster; Frank Schmitz; Matthias Schiemann; Dirk H Busch; Hermann Wagner
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

4.  Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells.

Authors:  Jean Francois Fonteneau; Daniel G Kavanagh; Margareta Lirvall; Catherine Sanders; Timothy L Cover; Nina Bhardwaj; Marie Larsson
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

5.  Quantitating protein synthesis, degradation, and endogenous antigen processing.

Authors:  Michael F Princiotta; Diana Finzi; Shu-Bing Qian; James Gibbs; Sebastian Schuchmann; Frank Buttgereit; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

6.  Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming.

Authors:  Stefan Freigang; Denise Egger; Kurt Bienz; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

7.  ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.

Authors:  Pierre Guermonprez; Loredana Saveanu; Monique Kleijmeer; Jean Davoust; Peter Van Endert; Sebastian Amigorena
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

8.  Phagosomes are competent organelles for antigen cross-presentation.

Authors:  Mathieu Houde; Sylvie Bertholet; Etienne Gagnon; Sylvain Brunet; Guillaume Goyette; Annie Laplante; Michael F Princiotta; Pierre Thibault; David Sacks; Michel Desjardins
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

9.  Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells.

Authors:  Brent Berwin; Justin P Hart; Stuart Rice; Cecilia Gass; Salvatore V Pizzo; Steven R Post; Christopher V Nicchitta
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

10.  HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation.

Authors:  Paul A MacAry; Babak Javid; R Andres Floto; Kenneth G C Smith; Wulf Oehlmann; Mahavir Singh; Paul J Lehner
Journal:  Immunity       Date:  2004-01       Impact factor: 31.745
View more
  26 in total

1.  Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.

Authors:  Suzanne Foster; Craig L Duvall; Emily F Crownover; Allan S Hoffman; Patrick S Stayton
Journal:  Bioconjug Chem       Date:  2010-11-02       Impact factor: 4.774

Review 2.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8(+) T cell responses to rabies virus.

Authors:  Celestine N Wanjalla; Elizabeth F Goldstein; Christoph Wirblich; Matthias J Schnell
Journal:  Virology       Date:  2012-02-16       Impact factor: 3.616

4.  Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns.

Authors:  Sebastian Bunk; Hanne Schaffert; Bianca Schmid; Christoph Goletz; Sabine Zeller; Marina Borisova; Florian Kern; Jan Rupp; Corinna Hermann
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

Review 5.  Evolutionary and functional relationships of B cells from fish and mammals: insights into their novel roles in phagocytosis and presentation of particulate antigen.

Authors:  J Oriol Sunyer
Journal:  Infect Disord Drug Targets       Date:  2012-06

6.  Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.

Authors:  Taheri Sathaliyawala; Mangala Rao; Danielle M Maclean; Deborah L Birx; Carl R Alving; Venigalla B Rao
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.

Authors:  Nicholas J Steers; Kristina K Peachman; Sasha R McClain; Carl R Alving; Mangala Rao
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 8.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

Review 9.  Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer.

Authors:  Roger Li; Jingsong Zhang; Scott M Gilbert; José Conejo-Garcia; James J Mulé
Journal:  Nat Rev Urol       Date:  2021-06-28       Impact factor: 14.432

10.  Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells.

Authors:  Sung Nam Park; Kyung Tae Noh; Young-Il Jeong; In Duk Jung; Hyun Kyu Kang; Gil Sun Cha; Su Jung Lee; Jong Keun Seo; Dae Hwan Kang; Tae-Ho Hwang; Eun Kyung Lee; Byungsuk Kwon; Yeong-Min Park
Journal:  Exp Mol Med       Date:  2013-02-08       Impact factor: 8.718
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.